.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Farmers Insurance
Daiichi Sankyo
Colorcon
McKinsey
Merck
Novartis
Cipla
Chubb

Generated: December 17, 2017

DrugPatentWatch Database Preview

PENETREX Drug Profile

« Back to Dashboard

When do Penetrex patents expire, and what generic alternatives are available?

Penetrex is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in PENETREX is enoxacin. There are three drug master file entries for this compound. Additional details are available on the enoxacin profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-004Dec 31, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-005Dec 31, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PENETREX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Julphar
Federal Trade Commission
Argus Health
Express Scripts
Fish and Richardson
Baxter
Healthtrust
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot